These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 2958456)

  • 61. Calcium antagonizes the magnesium-induced high affinity state of the hepatic vasopressin receptor for the agonist interaction.
    Wang H; Gopalakrishnan V; McNeill JR; Sulakhe PV; Triggle CR
    Br J Pharmacol; 1990 May; 100(1):5-10. PubMed ID: 2372661
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Physical and functional association of follitropin receptors with cholera toxin-sensitive guanine nucleotide-binding protein.
    Dattatreyamurty B; Figgs LW; Reichert LE
    J Biol Chem; 1987 Aug; 262(24):11737-45. PubMed ID: 3114250
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Characterization of the human liver vasopressin receptor. Profound differences between human and rat vasopressin-receptor-mediated responses suggest only a minor role for vasopressin in regulating human hepatic function.
    Howl J; Ismail T; Strain AJ; Kirk CJ; Anderson D; Wheatley M
    Biochem J; 1991 May; 276 ( Pt 1)(Pt 1):189-95. PubMed ID: 2039469
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Evidence of two steps in the homologous desensitization of vasopressin-sensitive phospholipase C in WRK1 cells. Uncoupling and loss of vasopressin receptors.
    Cantau B; Guillon G; Alaoui MF; Chicot D; Balestre MN; Devilliers G
    J Biol Chem; 1988 Jul; 263(21):10443-50. PubMed ID: 2968982
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Hormonal regulation of Gi2 alpha-subunit phosphorylation in intact hepatocytes.
    Bushfield M; Murphy GJ; Lavan BE; Parker PJ; Hruby VJ; Milligan G; Houslay MD
    Biochem J; 1990 Jun; 268(2):449-57. PubMed ID: 2114093
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [ADH and cAMP receptor binding in the kidney medulla of mice insensitive to ADH].
    Solenov EI; Zelenina MN; Ivanova LN
    Fiziol Zh SSSR Im I M Sechenova; 1991 May; 77(5):85-91. PubMed ID: 1666385
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Interaction of rat adenohypophyseal vasopressin receptors with vasopressin analogues substituted at positions 7 and 1: dissimilarity from the V1 vasopressin receptor.
    Knepel W; Götz D; Fahrenholz F
    Neuroendocrinology; 1986; 44(3):390-6. PubMed ID: 3027602
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Affinity purification of angiotensin type 2 receptors from N1E-115 cells: evidence for agonist-induced formation of multimeric complexes.
    Siemens IR; Yee DK; Reagan LP; Fluharty SJ
    J Neurochem; 1994 Jan; 62(1):257-64. PubMed ID: 8263526
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Purification and characterization of the rat pancreatic cholecystokinin receptor.
    Duong LT; Hadac EM; Miller LJ; Vlasuk GP
    J Biol Chem; 1989 Oct; 264(30):17990-6. PubMed ID: 2808360
    [TBL] [Abstract][Full Text] [Related]  

  • 70. L6 skeletal muscle cells have functional V1-vasopressin receptors coupled to stimulated inositol phospholipid metabolism.
    Wakelam MJ; Patterson S; Hanley MR
    FEBS Lett; 1987 Jan; 210(2):181-4. PubMed ID: 2947815
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Identification of specific vasopressin binding sites in cell membranes of the adenohypophysis, liver, kidney and adrenal glands of the rat].
    Korneev AIa; Bragin EO
    Biull Eksp Biol Med; 1989 Oct; 108(10):461-4. PubMed ID: 2532044
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Characterization of nuclear angiotensin-II-binding sites in rat liver and comparison with plasma membrane receptors.
    Tang SS; Rogg H; Schumacher R; Dzau VJ
    Endocrinology; 1992 Jul; 131(1):374-80. PubMed ID: 1612017
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The formylpeptide chemoattractant receptor copurifies with a GTP-binding protein containing a distinct 40-kDa pertussis toxin substrate.
    Polakis PG; Uhing RJ; Snyderman R
    J Biol Chem; 1988 Apr; 263(10):4969-76. PubMed ID: 2832415
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Interaction of a vasopressin antagonist with vasopressin receptors in the septum of the rat brain.
    Dorsa DM; Brot MD; Shewey LM; Meyers KM; Szot P; Miller MA
    Synapse; 1988; 2(3):205-11. PubMed ID: 2975069
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Vasopressin receptor subtypes: autoradiographic localization of V1 vasopressin binding sites in rat brain and kidney.
    Fahrenholz F; Gerstberger R
    J Protein Chem; 1989 Jun; 8(3):370-2. PubMed ID: 2551317
    [No Abstract]   [Full Text] [Related]  

  • 76. Vasopressin receptors in the brain, liver and kidney of rats following osmotic stimulation.
    Landgraf R; Szot P; Dorsa DM
    Brain Res; 1991 Mar; 544(2):287-90. PubMed ID: 1828184
    [TBL] [Abstract][Full Text] [Related]  

  • 77. A comparative study of plasma vasopressin levels and V1 and V2 vasopressin receptor properties in congenital hypothyroid rat under thyroxine or vasopressin therapy.
    Ali M; Guillon G; Cantau B; Balestre MN; Chicot D; Clos J
    Horm Metab Res; 1987 Dec; 19(12):624-8. PubMed ID: 2964396
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Size of vasopressin receptors from rat liver and kidney.
    Guillon G; Couraud PO; Butlen D; Cantau B; Jard S
    Eur J Biochem; 1980 Oct; 111(1):287-94. PubMed ID: 6254775
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Benzophenanthridine alkaloids isolated from Eschscholtzia californica cell suspension cultures interact with vasopressin (V1) receptors.
    Granger I; Serradeil-le Gal C; Augereau JM; Gleye J
    Planta Med; 1992 Feb; 58(1):35-8. PubMed ID: 1535715
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Affinity capture of [Arg8]vasopressin-receptor complex using immobilized antisense peptide.
    Lu FX; Aiyar N; Chaiken I
    Proc Natl Acad Sci U S A; 1991 May; 88(9):3642-6. PubMed ID: 2023913
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.